Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
13.81
+0.14 (1.02%)
At close: Feb 2, 2026, 4:00 PM EST
13.81
0.00 (0.00%)
After-hours: Feb 2, 2026, 4:00 PM EST
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $1.08 billion as of February 2, 2026. Its market cap has increased by 126.54% in one year.
Market Cap
1.08B
Enterprise Value
1.53B
1-Year Change
126.54%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $1.08B, an increase of 104.53%. That is a compound annual growth rate of 12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 1.08B | -8.38% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 1.14B |
| Inventiva | 1.13B |
| Capricor Therapeutics | 1.13B |
| EyePoint | 1.12B |
| MoonLake Immunotherapeutics | 1.12B |
| Inhibrx Biosciences | 1.11B |
| AbCellera Biologics | 1.08B |
| Aktis Oncology | 1.06B |